Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered into a license agreement with Recordati (“Recordati”), under which Recordati obtained exclusive rights to develop and ...
Pomerantz LLP is investigating claims on behalf of investors of AECOM (“AECOM” or the “Company”) (NYSE: ACM). Such investors are advised to ...
A good software architecture ensures that an AI system does not depend on the performance of a specific model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results